Cargando…
Acute Intravenous Injection Toxicity Study of Escherichia coli-Derived Recombinant Human Bone Morphogenetic Protein-2 in Rat
STUDY DESIGN: Prospective in vivo toxicity study. PURPOSE: To evaluate the conducted acute toxicity study of Escherichia coli (E. coli)-derived recombinant human bone morphogenetic protein-2 (rhBMP-2) with 6-weeks old Sprague-Dawley rats. OVERVIEW OF LITERATURE: rhBMP-2 has well-known osteoinductivi...
Autores principales: | Lee, Jae Hyup, Lee, Eui-Nam, Chang, Bong-Soon, Lee, Choon-Ki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Spine Surgery
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996333/ https://www.ncbi.nlm.nih.gov/pubmed/24761191 http://dx.doi.org/10.4184/asj.2014.8.2.113 |
Ejemplares similares
-
Synergistic induction of early stage of bone formation by combination of recombinant human bone morphogenetic protein-2 and epidermal growth factor
por: Lee, Jae Hyup, et al.
Publicado: (2015) -
Modulation of osteogenic differentiation by Escherichia coli-derived recombinant bone morphogenetic protein-2
por: Kim, Nam-Hyun, et al.
Publicado: (2022) -
Anterior Cervical Discectomy and Fusion Using Escherichia coli-Derived Recombinant Human Bone Morphogenetic Protein-2: A Pilot Study
por: Son, Hee Jung, et al.
Publicado: (2022) -
Comparison of demineralized bone matrix and hydroxyapatite as carriers of Escherichia coli recombinant human BMP-2
por: Jin, Yuan-Zhe, et al.
Publicado: (2021) -
Effectiveness and Feasibility of Injectable Escherichia coli‐Derived Recombinant Human Bone Morphogenetic Protein‐2 for Anterior Lumbar Interbody Fusion at the Lumbosacral Junction in Adult Spinal Deformity Surgery: A Clinical Pilot Study
por: Im, Sang‐Kyu, et al.
Publicado: (2022)